Renal Cancer - Results from #60

PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients. November 4, 2024

The future of cellular therapy for the treatment of renal cell carcinoma. November 4, 2024

Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma. November 1, 2024

AI predictive modeling of survival outcomes for renal cancer patients undergoing targeted therapy. November 1, 2024

Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older. October 31, 2024

Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power. October 31, 2024

Factors associated with surgical refusal and non-surgical candidacy in stage 1 kidney cancer: a National Cancer Database (NCDB) analysis. October 30, 2024

Impact of a kidney-adjusted ERAS® protocol on postoperative outcomes in patients undergoing partial nephrectomy. October 29, 2024

Meta-analysis and systematic review of factors predicting conversion to radical nephrectomy following robotic-assisted partial nephrectomy in renal cancer patients. October 29, 2024

T1a renal cancer cryoablation - first experiences in Poland. October 28, 2024

Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learning. October 28, 2024

Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients. October 25, 2024

Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives. October 25, 2024

Beyond Index Conditions: Applying a Multimorbidity Approach to Renal Cancer Nursing. October 25, 2024

Resveratrol enhances sensitivity of renal cell carcinoma to tivozanib: An in-vitro study. October 24, 2024

GLYAT suppresses liver cancer and clear cell renal cell carcinoma progression by downregulating ROCK1 expression. October 24, 2024

Cytoreductive Nephrectomy Following Immunotherapy for Metastatic Renal Cell Carcinoma and IVC Tumor Thrombus Arising from a Horseshoe Kidney. October 23, 2024

Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors. October 23, 2024

Prognosis and progression of phagocytic regulatory factor-related gene combinations in clear cell renal cell carcinoma (ccRCC). October 22, 2024

A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy. October 22, 2024

Page 4 of 456